Name: GENESIS IBRC INDIA LIMITED Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 307 across all filing types

Latest filing 2026-05-22 Regulatory Filings

Country IN India

Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing	Released	Lang
CCME Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Intimation of the board meeting .... Regulatory Filings	2026-05-22	English
Intimation about receipt of listing approval for 32250000 equity shares allotted on March 26, 2026 Regulatory Filings	2026-04-30	English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2026-04-17	English
Company Secretary designated as Key Managerial Personnel. Regulatory Filings	2026-04-08	English
Situation of corporate office and keeping books of accounts at the office other than registered office. Regulatory Filings	2026-04-08	English
Appointment of Company Secretary, Compliance Officer and KMP. Regulatory Filings	2026-04-08	English

Browse filings by year

8 years

	ID	Filing	Released	Lang
2026 15 filings
	46797698	CCME Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Intimation of the board meeting .... Regulatory Filings	2026-05-22	English
	46230682	Intimation about receipt of listing approval for 32250000 equity shares allotted on March 26, 2026 Regulatory Filings	2026-04-30	English
	46230698	Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2026-04-17	English
	46230686	Company Secretary designated as Key Managerial Personnel. Regulatory Filings	2026-04-08	English
	46230693	Situation of corporate office and keeping books of accounts at the office other than registered office. Regulatory Filings	2026-04-08	English
	46230690	Appointment of Company Secretary, Compliance Officer and KMP. Regulatory Filings	2026-04-08	English
	46230706	Outcome of board meeting for appointment of Company Secretary, Compliance Officer and KMP. Also for situation of corporate office and keeping books of accounts at the place other than the .... Regulatory Filings	2026-04-08	English
	46230712	Compliance certificate for the quarter ended on March 31, 2026. Regulatory Filings	2026-04-06	English
	46230702	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V Varalakshmi Regulatory Filings	2026-03-30	English
	46230709	The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmanaban Krishnamoorthy Regulatory Filings	2026-03-30	English
	46230719	Intimation for allotment of equity shares which were issued on preferential basis. Regulatory Filings	2026-03-26	English
	46230716	Closure of trading window for the fourth quarter and financial year ended on March 31, 2026 Regulatory Filings	2026-03-26	English
	46230726	The Company has received in-principle approval from BSE Limited for issue of equity shares to promoters and non-promoters on preferential basis. Regulatory Filings	2026-03-13	English
	46230723	Update on change in name that the Company has received in-principle approval from the stock exchange for change in name of the Company. Approval letter received from stock exchange is enclosed. Regulatory Filings	2026-03-12	English
	46230741	Voting results and scrutinizer''s report for the postal ballot of the Company. Regulatory Filings	2026-03-06	English

Page 1 of 21

1 2 3 … Next

Market data

Market data not available

Peer group · Manufacture of other chemical products n.e.c.

533 peers

Company	Ticker	Country	Sector
1933 Industries Inc A vertically integrated consumer-packaged goods company spe…	TGIF	CA	Manufacturing
3M CO A diversified, science-based technology corporation that de…	MMM	US	Manufacturing
5N Plus Inc. Global producer of specialty semiconductors and ultra-pure …	VNP	CA	Manufacturing
ACISELSAN ACIPAYAM SELÜLOZ SANAYİ VE TİCARET A.Ş. Specialized manufacturer of Carboxymethyl Cellulose (CMC) f…	ACSEL	TR	Manufacturing
ACUTAAS CHEMICALS LIMITED Manufactures and exports specialty chemicals for industrial…	ACUTAAS	IN	Manufacturing
ADEKA CORPORATION Manufacturer of chemicals, food products, and life sciences…	4401	JP	Manufacturing
Ading AD Manufactures and distributes chemical materials for the con…	AD	MK	Manufacturing
Aduro Clean Technologies Inc. Uses a water-based chemical process to convert hydrocarbon …	ADUR	CA	Manufacturing
Advanced Enzyme Technologies Limited Research-driven developer and manufacturer of proprietary e…	ADVENZYMES	IN	Manufacturing
Advanced Nano Products Co., Ltd. Developer and manufacturer of advanced nanomaterials for hi…	121600	KR	Manufacturing

Page 1 of 54

1 2 3 … Next

GENESIS IBRC INDIA LIMITED via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID63211

Ticker514336

ISININE194N01016

Endpoints

most-used routes for this company

GET	/api/companies/63211/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=63211	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=63211	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for GENESIS IBRC INDIA LIMITED

$ curl https://api.financialreports.eu/api/filings/?company=63211 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 63211},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for GENESIS IBRC INDIA LIMITED (id: 63211)"

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings